Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Actylis operates as a specialized services and supply chain partner for industries requiring high-quality raw materials and ingredients, particularly in drug delivery and small molecule development. It provides a critical link in the supply chain through strategic sourcing, custom and toll manufacturing, and comprehensive quality and regulatory support. The company's value proposition centers on simplifying complex supply chains, mitigating risk, and enabling its partners to focus on core R&D and commercialization. With a global operational footprint and deep expertise, it positions itself as an agile and reliable partner in a fragmented and challenging market.

Drug DeliverySmall Molecules

Technology Platform

Integrated global service platform for sourcing, custom/toll manufacturing, quality/regulatory compliance, and supply chain logistics management of critical ingredients and raw materials.

Funding History

1
UndisclosedUndisclosed

Opportunities

Strong demand for supply chain outsourcing and risk mitigation in life sciences, driven by complexity, regulation, and geopolitical instability.
Growth in custom manufacturing for novel drug delivery systems and small-batch personalized therapies.
Potential to expand service offerings into digital supply chain solutions and advanced analytics.

Risk Factors

Exposure to global supply chain disruptions and geopolitical tensions.
Dependence on key clients and cyclical end-markets.
Intense competition from large distributors and niche service providers.
Significant regulatory compliance burden across multiple industries and regions.

Competitive Landscape

Competes with large chemical and pharmaceutical distributors (e.g., Sigma-Aldrich/MilliporeSigma, Thermo Fisher), specialized sourcing and manufacturing service providers (CDMOs), and regional chemical suppliers. Differentiation is based on integrated service breadth, deep regulatory expertise, and a client-partnership model emphasizing customization and supply chain agility.